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Abstract
The gastrointestinal functions of secretin have been  
fairly well established. However, its function and  
mode of action within the nervous system remain  
largely unclear. To gain insight into this area, we have  
attempted to determine the effects of secretin on  
neuronal differentiation. Here, we report that secretin  
induces the generation of neurite outgrowth in  
pheochromocytoma PC12 cells. The expressions of 
Tau and beta-tubulin, neuronal differentiation mark -
ers, are increased upon secretin stimulation. In  
addition, secretin induces sustained mitogen-acti-
vated protein kinase (MAPK) activation and also  
stimulates the cAMP secretion. Moreover, the neurite  
outgrowth elicited by secretin is suppressed to a  
marked degree in the presence of either PD98059, a  
specific MAPK/ERK kinase (MEK) inhibitor, or H89, 
a specific protein kinase A (PKA) inhibitor. Taken  
together, these observations demonstrate that 
secretin induces neurite outgrowth of PC12 cells  
through cAMP- MAPK pathway, and provide a novel 
insight into the manner in which secretin participates  
in neuritogenesis.
Keywords: mitogen-activated protein kinases; neu-
rites; pheochromocytoma; secretin; tau proteins
Introduction
Secretin has been shown to belong to a peptide 
family which includes vasoactive intestinal poly-
peptide (VIP), pituitary adenylate cyclase-activating 
polypeptide (PACAP), and glucagon-like peptide. 
Members of this peptide family have also been 
determined to function as ligands for known G- 
protein-coupled receptors (Dong and Miller, 2002). 
Most of the peptides in this group have been 
detected both peripherally and centrally, thereby 
reflecting their known hormonal role within the 
gastrointestinal system, and suggesting that they 
may also play a role in neuronal function. Further-
more, secretin receptors have been shown to be 
expressed in mammalian brain tissues, including the 
cerebellum (Fremeau et al., 1983; Nozaki et al., 
2002). 
    Rat pheochromocytoma PC12 cells have been 
previously utilized in a model system for the study of 
the intracellular signaling pathway which leads to 
neuronal differentiation. Stimulation with differen-
tiating factors, including nerve growth factor (NGF), 
and the subsequent activation of its receptor, TrkA, 
were demonstrated to initiate a variety of signaling 
events which led to the cessation of growth, the 
acquirement of electrical excitability, the expression 
of neuron-specific marker proteins, and the ex-
tension of neurites (Hagag et al., 1986; Leoni et al., 
1999; Grumolato et al., 2003). Neurite extension 
induced by different stimuli was determined to be a 
distinctive aspect of neuronal differentiation (Bouron 
et al., 1999). 
    The signal pathways involved in neuronal differen-
tiation have been studied extensively. Sustained 
mitogen activated protein kinase (MAPK) activation 
has been confidently implicated in NGF-induced 
neurite outgrowth occurring in PC12 cells (Traverse 
et al., 1992; Nguyen et al., 1993; Pang et al., 1995). 
Neurite outgrowth in PC12 cells has been experi-
mentally induced by NGF, but not by epidermal 
growth factor (EGF). This differential response was 
attributed to the difference in the duration of MAPK 
activation; NGF induced a sustained MAPK acti-
vation, but EGF resulted in only a short-lived 
activation (Yasui et al., 2001). On the other hand, the 
regulation of intracellular cAMP levels has been 
implicated in the control of a variety of biological 
functions, including neuronal differentiation. cAMP 
appears to generate a powerful survival and differen-
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tiation signal for neurons (Rydel and Greene, 1988; 
Piiper et al., 2002). Under serum-free conditions, 
cAMP was shown to sustain survival, and to pro-
mote the neurite outgrowth in neurons. cAMP- 
induced neuronal differentiation has been generally 
thought to be involved in the phosphorylation of 
transcription factors (Montminy, 1997). However, the 
identity of the intracellular signaling molecules which 
mediate neuronal differentiation has yet to be 
precisely determined.
    The objective of this study was to obtain more 
insight into the molecular mechanisms involved in 
secretin-mediated neuritogenesis. In this study, we 
have evaluated the effects of secretin on both MAPK 
activity and cAMP generation. Here, we present the 
data suggesting that the cAMP-MAPK pathway 
might be involved in secretin-mediated neurito-
genesis. 
Materials and Methods
Reagents
The synthetic secretin and VIP used in this study 
were obtained (Phoenix Pharmaceuticals, Inc. 
Mountain View, CA). The anti-phosphoTrkA/Akt/ERK1 
/2(Thr 202/Thy 204), anti-Akt/ERK1/2, and anti-beta 
tubulin antibodies were purchased (New England 
Biolabs, Beverly, MA) and the secondary antibodies 
conjugated to horse radish peroxidase were bought 
(Kirkegaard and Perry Lab, Gaithersburg, MD). The 
NGF was purchased (Upstate Biotechnology Incor-
porated, Lake Placid, NY). The dibutyryl-cAMP, H89, 
and rapamycin were bought (Calbiochem, Stras-
bourg, France). The PD98059 was obtained (Alexis, 
Coger, France). 
Cell culture
The PC12 cells were grown in culture medium 
containing 500 ml of RPMI 1640 (GIBCOTM, Auck-
land, NZ) supplemented with 0.584 g/liter L-gluta-
mate and 4.5 g/liter of glucose, mixed with 500 ml of 
F-12 medium containing 0.146 g/liter of L-glutamate, 
1.8 g/liter of glucose, 100 g/ml of gentamicin, 2.5 
g/liter of sodium carbonate, 5% heat-inactivated fetal 
bovine serum (FBS), and 10% horse serum. 
Immunoblot analysis
The PC12 cells were allowed to grow in 6-well plates 
until achieving 60-70% confluence, after which they 
were serum-starved for 24 hours prior to the 
administration of treatment with selected agents. 
The media were then aspirated, and the cells were 
washed twice in ice-cold PBS, then lysed in 100 l of 
lysis buffer (0.5% deoxycholate, 0.1% SDS, 1% 
Nonidet P-40, 150 mM NaCl and 50 mM Tris-HCl, 
pH 8) supplemented with proteinase inhibitors (0.5 
M aprotinin, 1 M phenylmethylsulfonyl fluoride, 1 
M leupeptin) (Sigma-Aldrich, St. Louis, MO). These 
samples were sonicated briefly, heated for 5 minutes 
at 95oC, then centrifuged for another 5 minutes. The 
supernatants were electrophoresed on SDS-PAGE 
(8-16%) gradient gels, and transferred to polyvi-
nylidene difluoride membranes. The blots were then 
incubated overnight at 4oC with primary antibodies, 
and washed 6 times with Tris-buffered saline/0.1% 
Tween 20 prior to 1 hour of probing with horseradish 
peroxidase-conjugated secondary antibodies at room 
temperature. The blots were then visualized using 
ECL (Amersham Biosciences, Buckinghamshire, UK). 
In some cases, the blots were stripped and reprobed 
with other antibodies. 
Immunocytochemistry  
The PC12 cells were plated on poly-L-lysine-coated 
glass coverslips and maintained in growth media. 
After 1 day of culture, this medium was replaced with 
media containing 1% FBS supplemented with se-
cretin or NGF, then cultured for an additional 2 days. 
For the immunofluorescence microscopy, the cul-
tured cells were washed in PBS and fixed in 4% 
paraformaldehyde in PBS for 1 hour, then per-
meabilized for 15 minutes with 0.1% Triton X-100 
and blocked with 20% skimmed milk for 30 minutes. 
The cells were incubated for 1 hour with primary 
anti-Tau antibody. After another washing with PBS, 
the cells were incubated with secondary FITC- 
conjugated monoclonal antibody (Molecular probes, 
Eugene, OR) for 1 hour. After incubation, the sam-
ples were washed in PBS, and then visualized using 
a confocal microscope (Zeiss LSM 510 Meta, Ober-
kochen, Germany).
Neurite outgrowth  
The PC12 cells were plated on six-well collagen- 
coated plates in growth media. After 1 day, the 
medium was changed to 1% FBS medium con-
taining 1 M of secretin, and incubated for an 
additional 2 days. Then, the numbers and lengths of 
neurite outgrowth were counted and measured. 
Cells with neurite lengths of at least twice the 
diameter of the cell body were considered to be 
differentiated cells. All images were captured with a 
confocal microscope using the × 20 objective (Zeiss 
LSM 510 Meta, oberkochen, Germany).
RT-PCR
Levels of secretin receptor and GAPDH expression 
were determined via RT-PCR, as was described 
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Figure 1. Secretin induces the neurite outgrowth in PC 12 cells. PC12 cells were cultured in RPMI 1640 medium supple-
mented with 10% horse serum and 5% fetal bovine serum. A, in comparison to the control, both secretin and NGF induced the 
outgrowth of neurites from the cell body. The cells were incubated for 2 days in 1% FBS medium supplemented with secretin 
(1 M) secretin and NGF (10 ng/ml). Phase-contrast photographs were obtained using a confocal microscope, with the × 20 
objective. B, the percentage of neurite-containing cells was calculated from 5 random fields in one well. The data are ex-
pressed as a mean percentage of 4 wells in one representative experiment. Statistical analyses were performed. The data are 
expressed as means ± S.E. *P ＜ 0.01 compared with untreated cells. C, effect of secretin on Tau or beta-tubulin expression. 
The cells were incubated for 2 days in 1% FBS medium supplemented with secretin and NGF. The cell lysates were analyzed 
via immunoblotting with anti-Tau antibody. Protein loading was normalized via immunoblotting with anti-actin antibody. D, the 
PC12 cells were plated on collagen-coated cover glasses. After 24 hours, the PC12 cells were stimulated for 2 hours with ei-
ther secretin or NGF. After incubation with primary anti-Tau antibody and secondary FITC-conjugated monoclonal antibody, we 
captured the images with a confocal microscope using the x 20 objective. E, RT-PCR analysis of secretin receptors in PC12 
cells. Total RNA was prepared from the PC12 cells and RT-PCR was conducted using a specific secretin receptor primer. The 
PCR products were then gel-run in 2% agarose, and visualized in UV. GAPDH mRNA was employed as a positive control. 
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below. The synthetic oligonucleotide primer sequen-
ces for secretin receptor and GAPDH were as 
follows; GAPDH(forward), 5'-CGATGCTGGCGCTG-
AGTAC-3', GAPDH(reverse), 5'-CGTTCAGCTCAG-
GGATGACC-3' and secretin receptor (forward), 5'- 
TGTTCGTGTCCTTCATCCTG-3', secretin receptor 
(backward), 5'-GAAGGAGATGGCAAGGAGTG-3'. We 
conducted PCR amplification on the above-listed 
primers in a 25- l reaction tube. The following pro-
gram was utilized for 30 cycles of amplification in a 
Gene Amp PCR System 2400 (Perkin Elmer, 
Wellesley, MA): 30 seconds at 94oC, 30 seconds at 
62oC and 30 seconds at 72oC. The amplified DNA 
fragments were then electrophoresed on 2% 
agarose gel and, and stained with ethidium bromide. 
cAMP measurement
The cAMP content in the PC12 cell lysates were 
determined via commercial ELISA assays (Amer-
sham Biosciences, Piscataway, NJ). The cells were 
preincubated with 1 mM IBMX for 15 minutes, in 
order to inhibit any endogenous cAMP-phospho-
diesterase. The cells were then treated for 10 
minutes with the specified agents. The cAMP con-
tents were calculated using a standard curve, and 
normalized to total amylase contents. 
Data analysis  
Data are expressed as the means ± S.E.M. 
Statistical analyses were conducted using SigmaStat 
(SPSS Inc., Chicago). Differences were regarded as 
significant at a p value of ＜ 0.05. Comparisons 
between basal and stimulated status were analyzed 
via ANOVA with Holm-Sidak comparisons. 
Results
Secretin induces the neurite outgrowth in
PC 12 cells  
To address secretin’s functions in neuronal di-
fferentiation, we first investigated the effects of se-
cretin on the neurite outgrowth of pheochromo-
cytoma PC12 cells. The application of secretin (1 
M) was found to induce the generation of neurite 
outgrowth in these cells (Figure 1A). Both the 
number of neurites and the length of the branches 
were determined to have increased as the result of 
secretin stimulation (Figure 1B). NGF, a well-known 
differentiating factor, was employed in an effort to 
induce the neurite outgrowth, and was used as a 
positive control. Tau, a microtubule-associated pro-
tein which is also used as a neuronal differential 
marker, was found to be unique neuronal component 
which stabilized microtubules, resulting in the 
formation of axonal processes (Caceres and Kosik, 
1990; Esmaeli-Azad et al., 1994; Hirokawa et al., 
1996). To ascertain whether secretin-induced neurite 
outgrowth was correlated with the induction of the 
protein, we conducted Western blot analyses to 
determine the expressions of neuronal differentiation 
markers, Tau and beta-tubulin. The levels of these 
proteins were increased by secretin, and were also 
increased as the result of NGF treatment (10 ng/mL) 
(Figure 1C). Our cytochemical analyses showed that 
the subcellular localization of Tau was enriched in 
the neurites, especially in the branch regions, after 
stimulation with secretin (Figure 1D). Next, in order 
to confirm the existence of the secretin receptor in 
the PC12 cells, we conducted an RT-PCR experi-
ment. Secretin receptor mRNA was clearly shown to 
be expressed in these cells (Figure 1E). GAPDH 
mRNA was constitutively expressed, and was used 
as a positive control for the RT-PCR experiment. 
These results clearly showed that secretin possess-
ed the ability to induce the neurite outgrowth in the 
PC 12 cells. 
The MAPK pathway is involved in the 
secretin-induced neuritogenesis
To better understand the signal pathways involved in 
neuritogenesis, we attempted to assess the effects 
of secretin on the activity of several signal pathways. 
The phosphorylation of p42/44 MAPK was increased 
by secretin (1 M) as well as NGF (10 ng/ml) (Figure 
2A, B). The phosphorylation patterns in these cells 
reached maximal levels at 10 minutes, and persisted 
for 3 hours. These results were consistent with 
previous reports that sustained MAPK activation was 
crucial for neuritogenesis in PC12 cells (Yasui et al., 
2001). To confirm the involvement of the MAPK 
pathway, we pre-treated the cells with PD98059 (2 
M) prior to secretin treatment, and then assessed 
the degree of differentiation in the cells. The neurite 
outgrowth induced by both secretin and NGF was 
suppressed significantly by PD98059 pretreatment 
(Figure 2C). Rapamycin (10 M) was used as a 
negative control and showed no effects on secretin 
or NGF-induced neurite outgrowth. The stimulatory 
effects of these two components on MAPK dis-
appeared in the presence of PD98059 (Figure 2E). 
These results suggested that the MAPK pathway 
might be associated with secretin-induced neuri-
togenesis. 
Secretin stimulates cAMP generation in PC12 cells
To elucidate the molecular mechanisms underlying 
secretin-induced neuronal differentiation, we then 
attempted to characterize the effects of secretin on 
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Figure 2. The MAPK pathway is involved in the secretin-induced neuritogenesis. A and B, the effects of secretin and NGF on MAPK activity. PC12 
cells were stimulated with either secretin (1 M) or NGF (10 ng/ml) for the indicated times. The cell lysates were then analyzed via immunoblotting 
with anti-phospho ERK1/2 antibodies. Protein loading was normalized via immunoblotting with anti-ERK1/2 antibodies. C, the effects of PD98059 
on neurite outgrowth. PC12 cells were plated on collagen-coated dishes. After 24 hours, the cells were incubated in 1% FBS medium supple-
mented with either secretin or NGF, in the presence of PD98059 (2 M) or rapamycin (10 M), respectively. After 2 days, the cells were photo-
graphed with a confocal microscope, using the × 20 objective. D, the percentage of cells with neurites were calculated from 5 random fields in one 
well. The data were expressed as a mean percentage from 4 wells in one representative experiment. Statistical analyses were performed. The data 
are expressed as means ± S.E. *P ＜ 0.01 compared with untreated cells. E, the effects of PD98059 on MAPK activation. Cells were incubated in 
1% FBS medium under the indicated conditions, in the absence or the presence of PD98059. The cell lysates were analyzed via immunoblotting 
with anti-phospho ERK1/2 antibodies. Protein loading was normalized via immunoblotting with anti-ERK1/2 antibodies. 
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the generation of cAMP, as this was known to 
perform a critical function in neurite outgrowth in 
neurons (Rydel and Greene, 1988; Piiper et al., 
2002). Levels of cAMP were shown to have in-
creased upon stimulation with secretin, but this did 
not occur after NGF treatment (Figure 3A). Vaso-
active intestinal peptide (VIP) (1 M) was known to 
stimulate the generation of cAMP, and was used as 
a positive control in this experiment (Iwasaki et al., 
2001). To confirm this association with cAMP, we 
then pre-treated the cells with H89 (1 M), a specific 
PKA inhibitor, direct downstream of cAMP, prior to 
the administration of secretin treatment, and then 
attempted to characterize the differentiation occurr-
ing in the PC12 cells. Secretin-mediated neurite 
outgrowth was blocked completely when the cells 
were pre-treated with H89 (Figure 3B). To show the 
differential mechanisms between secretin and NGF, 
we attempted to ascertain whether or not secretin 
activated the NGF receptor, TrkA. TrkA was phos-
phorylated upon stimulation with NGF, but not by 
secretin treatment (Figure 3C). Phosphorylation of 
Akt, a downstream of TrkA, was also increased by 
the treatment with NGF, but not by secretin. These 
findings show that secretin may exert a neuritogenic 
effect via cAMP generation, rather than via the 
phosphorylation of Trk A.
cAMP plays a critical role in the secretin-induced  
neuritogenic effect 
To further confirm the role of cAMP in secretin- 
mediated neuritogenesis, we pre-treated the cells 
with H89 prior to administering secretin treatment, 
and then assessed the degree to which ERK1/2 
phosphorylation had occurred. Phosphorylation was 
determined to have increased in a dose-dependent 
manner with the treatment of dbcAMP (1 mM), a 
cAMP analogue (Figure 4A), and this activation was 
inhibited by treatment with H89 (Figure 4B). Finally, 
to confirm the role of MAPK in cAMP-mediated 
differentiation, we pre-treated the cells with PD98059 
Figure 3. Secretin stimulates cAMP secretion in PC12 cells. A, the effects of secretin or NGF on the generation of cAMP. PC12 cells were stimulated 
with secretin (1 M), NGF (10 ng/ml), and VIP (1 M). The amounts of secreted cAMP in the supernatant were then measured. Statistically significant 
(**P ＜ 0.01) differences were observed in the VIP and secretin-treated cells, as compared with the untreated cells. B, the effects of H89 (1 M) on 
secretin-mediated neurite outgrowth. PC12 cells were plated on collagen-coated dishes. After 24 hours, the cells were then incubated in 1% FBS me-
dium supplemented with secretin, in the presence of H89 (1 M) or rapamycin. After 2 days, the cells were photographed with a confocal microscope 
using the × 20 objective. C, effects of secretin or NGF on TrkA phosphorylation. PC12 cells were stimulated with either secretin or NGF. The cell ly-
sates were analyzed via immunoblotting with anti-phospho TrkA/Akt antibodies. Blotting with anti-actin antibody was conducted to normalize the quan-
tity of protein loading. 
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prior to the administration of dbcAMP, and then 
observed the morphological changes which occurred 
in the cells. cAMP-mediated neurite outgrowth was 
suppressed dramatically as the result of PD98059 
pre-treatment (Figure 4C). Overall, our findings im-
plied that the cAMP-MAPK pathway might be criti-
cally involved in secretin-induced neuritogenesis. 
Discussion
In our attempt to obtain a greater insight into the 
signal pathways involved in neuritogenesis, we have 
presented data which clearly suggest that the 
cAMP-MAPK pathway is involved in secretin-medi-
ated neurite outgrowth. We further reveal that the 
PC12 cells express secretin receptors at the mRNA 
level. 
    The intracisternal injection of secretin altered 
dopamine metabolism and prolactin secretion in rats 
(Fuxe et al., 1979) and its influence on cAMP levels 
was reported in brain cells (Propst et al., 1979). 
Secretin has also been determined to be expressed 
in distinct neuronal populations within the cere-
bellum and cerebral cortex (Couvineau et al., 1986; 
Yung et al., 2001). It has also been reported that VIP, 
which is structurally similar to secretin, exhibited 
neurite-promoting effects in ventral spinal cord cells 
(Iwasaki et al., 2001). In the present study, we have 
determined that secretin induces neurite outgrowth 
in PC12 cells, supporting the notion that secretin 
plays a role as a neurotrophic factor. This can be 
explained by the remarkable homology in structure 
observed between VIP and secretin (Mutt et al., 
1970). Amino acid residues consisted of 13 for VIP 
and 11 for secretin. Both peptides possessed COOH 
terminal amino acids; asparagines in VIP, and valine 
in secretin (Iwasaki et al., 2001). Although each 
receptor has a preferential affinity for its natural 
ligand, it may interact with a low affinity with the 
other peptide. Also, VIP and secretin cannot be 
shortened without a marked loss in biological po-
tency. Thus, the C-terminal domains of VIP and 
secretin are necessary for effector activation. There-
fore, it appears conceivable that amino acid residues 
of COOH terminal substances might play a role in 
neurite outgrowth. 
    In this study, we also observed that secretin 
activated the MAPK pathway, thereby indicating that 
secretin may elicit neuritogenesis, via the MAPK 
pathway. The involvement of the MAPK pathway in 
the commitment to cellular differentiation has been 
Figure 4. cAMP plays a critical role in the secretin-induced neuritogenic effect. A, effects of dbcAMP on the activity of MAPK. PC12 cells were stimu-
lated for 10 minutes with the indicated concentrations of dbcAMP. The cell lysates were then analyzed via immunoblotting with anti-phospho ERK1/2 
antibodies. Protein loading was normalized via immunoblotting with anti-ERK1/2 antibodies. B, the effects of H89 on the secretin-mediated activation 
of MAPK. The PC12 cells were stimulated with secretin (1 M), in the presence or absence of H89 (1 M). The cell lysates were analyzed via im-
munoblotting with anti-phospho ERK1/2 antibodies. C, the effects of PD98059 on dbcAMP-mediated neurite outgrowth. The PC12 cells were plated on 
collagen-coated dishes. After 24 hours, the cells were incubated in 1% FBS medium supplemented with dbcAMP (1 mM), in the absence or presence 
of PD98059 (2 M), respectively. After 2 days, the cells were photographed with a confocal microscope, using the × 20 objective. 
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studied rather extensively (Tojima et al., 2003). The 
differential response between NGF and EGF has 
been attributed to the duration of MAPK activation; 
NGF induces a sustained activation of MAPK, but 
EGF treatment results in only a short-lived activation 
(Yasui et al., 2001). Here, we have demonstrated 
that secretin also induces sustained MAPK acti-
vation. The data collected in this study are in basic 
agreement with a previous finding that the sustained 
activation of MAPK exerted a marked influence on 
neuronal differentiation in the PC12 cells. However, 
the mechanism by which secretin or VIP exhibits tro-
phic effects remains less than completely under-
stood. These peptides may exert direct effects on 
neurons, or may act indirectly through other cells, 
including glial cells. Glial cells are known to secrete 
neurotrophic factors. In the case of VIP, the sub-
stance has been demonstrated to exhibit trophic 
properties, and appears to act directly via cAMP 
(Brenneman et al., 1985; Brenneman and Eiden, 
1986). As was shown in this study, the secretin 
receptor was expressed in the PC12 cells. There-
fore, secretin may act directly on this cell, and thus 
generate cAMP. 
    In conclusion, we have determined and charac-
terized the effect of secretin on the differentiation of 
PC12 cells. Here, we have clearly shown that secre-
tin induces neuritogenesis, and exerts its effects in a 
distinct manner, rather than via the activation of the 
NGF receptor, TrkA. Further experiments will be 
required in order to determine the manner in which 
the secretin signal is interconnected with the 
intracellular signal pathways for differentiation. 
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